Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern Mozambique

• Status: Completed
• Trial end date: 2017-12-01
• Target enrollment: 0
• Participant gender: All

Summary

In line with the global and regional efforts towards malaria elimination, a five year program was established to assist the NMCP in adopting targeted evidence-based elimination plans through a 'learn by doing' strategy. The project aims to generate knowledge as data is generated to inform the programmatic aspects of the elimination plan, most importantly how to clear malaria parasites from the asymptomatic reservoir.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Centro de Investigacao em Saude de Manhica
• Collaborator: Barcelona Institute for Global Health
• Treatments: Artenimol; Dihydroartemisinin; Piperaquine

Criteria

Inclusion Criteria:

• Individuals who consent to participate in the study

• Residents in the study area

• Older than 6 months of age (or weighing more than 5Kg)

• Women in the second or third trimester who are not on IPTp

Exclusion Criteria:

• Individuals who do not consent to participate in the study

• Younger than 6 months of age (or weighing more than 5Kg)

• Women in the first trimester of pregnancy

• Severely ill individuals

• Individuals on contra-indicated medication